The legacy of nuclear risk and the founder effect in biotechnology organizations.
In the wake of the Chernobyl nuclear accident and a decline in the public trust of science, the founders of modern biotechnology recognized the strategic importance of risk assessment and regulatory affairs. In an effort to avoid the demonization that was attached to the nuclear industry, the pioneers of modern biotechnology delegated authority for regulatory negotiation and risk management to senior positions in the firm. At the same time, the Biotechnology Industry Organization was handed great latitude and trust with making public pronouncements on issues of bioethics and public policy. The way in which founders and leaders embed norms for negotiating regulation and responding to public perceptions has proved important in the maturation and acceptance of a biotechnology sector.
Fleising
Usher
U
Dept of Anthropology, University of Calgary, Calgary, Alberta, Canada. fleising@ucalgary.ca
D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence / Q000458:organization & administration* / Q000639:trends; D006801:Humans; D011050:Policy Making; D011210:Power Plants / Q000458:organization & administration*; D011639:Public Opinion; D011640:Public Policy; D018570:Risk Assessment / Q000639:trends; D012308:Risk Management / Q000639:trends*; D012952:Societies / Q000639:trends; D014481:United States